Unique ID issued by UMIN | UMIN000014381 |
---|---|
Receipt number | R000016734 |
Scientific Title | Clinical Study of Allogeneic Islet Transplantation for Treatment of type 1 diabetes |
Date of disclosure of the study information | 2014/06/26 |
Last modified on | 2014/06/25 18:41:20 |
Clinical Study of Allogeneic Islet Transplantation for Treatment of type 1 diabetes
Clinical Study of Allogeneic Islet Transplantation for Treatment of type 1 diabetes
Clinical Study of Allogeneic Islet Transplantation for Treatment of type 1 diabetes
Clinical Study of Allogeneic Islet Transplantation for Treatment of type 1 diabetes
Japan |
Type 1 Diabetes
Endocrinology and Metabolism | Hepato-biliary-pancreatic surgery |
Others
NO
the safety and efficacy of islet transplantation for the treatment of Type 1 Diabetes in subjects with hypoglycemia
unawareness and a history of severe hypoglycemic episodes
Safety,Efficacy
The proportion of subjects with an HbA1c <7.0% at Day 365 AND free of
severe hypoglycemic events from Day 28 to Day 365 inclusive following the
first islet transplant, with the day of transplant designated Day 0
Interventional
Single arm
Non-randomized
Open -no one is blinded
Active
1
Treatment
Medicine | Maneuver |
Allogeneic Islet Transplantation
20 | years-old | <= |
65 | years-old | >= |
Male and Female
Involvement in intensive diabetes management
Absent basal c-peptide (<0.1ng/mL)
At least one episode of severe hypoglycemia in the 12 months prior to study enrollment
Body mass index (BMI) >25 kg/m2 or patient weight >80kg.
Insulin requirement of >0.8 IU/kg/day or >55 U/day.
HbA1c >10%.
Untreated proliferative diabetic retinopathy.
Blood Pressure: SBP >160 mmHg or DBP >100 mmHg.
eGFR <60 mL/min/1.73m^2
Presence or history of macroalbuminuria (>1g/day).
Presence or history of panel-reactive anti-HLA antibodies above
background by flow cytometry.
3
1st name | |
Middle name | |
Last name | Masayuki Shimoda |
Research Institute, National Center for Global Health and Medicine
Pancreatic islet cell transplantation
1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655 Japan
03-3202-7181
mshimoda@hosp.ncgm.go.jp
1st name | |
Middle name | |
Last name | Masayuki Shimoda |
Research Institute, National Center for Global Health and Medicine
Pancreatic islet cell transplantation
1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655 Japan
03-3202-7181
mshimoda@hosp.ncgm.go.jp
National Center for Global Health and Medicine
National Center for Global Health and Medicine
NO
2014 | Year | 06 | Month | 26 | Day |
Unpublished
Open public recruiting
2014 | Year | 03 | Month | 07 | Day |
2014 | Year | 04 | Month | 01 | Day |
2014 | Year | 06 | Month | 26 | Day |
2014 | Year | 06 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016734
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |